These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 21763513)

  • 21. Current Technologies for Complex Glycoproteomics and Their Applications to Biology/Disease-Driven Glycoproteomics.
    Narimatsu H; Kaji H; Vakhrushev SY; Clausen H; Zhang H; Noro E; Togayachi A; Nagai-Okatani C; Kuno A; Zou X; Cheng L; Tao SC; Sun Y
    J Proteome Res; 2018 Dec; 17(12):4097-4112. PubMed ID: 30359034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toolbox Accelerating Glycomics (TAG): Glycan Annotation from MALDI-TOF MS Spectra and Mapping Expression Variation to Biosynthetic Pathways.
    Miura N; Hanamatsu H; Yokota I; Okada K; Furukawa JI; Shinohara Y
    Biomolecules; 2020 Sep; 10(10):. PubMed ID: 32998456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relative versus absolute quantitation in disease glycomics.
    Moh ES; Thaysen-Andersen M; Packer NH
    Proteomics Clin Appl; 2015 Apr; 9(3-4):368-82. PubMed ID: 25684231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identifying cancer biomarkers by mass spectrometry-based glycomics.
    Mechref Y; Hu Y; Garcia A; Hussein A
    Electrophoresis; 2012 Jul; 33(12):1755-67. PubMed ID: 22740464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent advances in mass spectrometric analysis of glycoproteins.
    Banazadeh A; Veillon L; Wooding KM; Zabet-Moghaddam M; Mechref Y
    Electrophoresis; 2017 Jan; 38(1):162-189. PubMed ID: 27757981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Automated annotation and quantification of glycans using liquid chromatography-mass spectrometry.
    Yu CY; Mayampurath A; Hu Y; Zhou S; Mechref Y; Tang H
    Bioinformatics; 2013 Jul; 29(13):1706-7. PubMed ID: 23610369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Towards automation of glycomic profiling of complex biological materials.
    Shubhakar A; Pang PC; Fernandes DL; Dell A; Spencer DIR; Haslam SM
    Glycoconj J; 2018 Jun; 35(3):311-321. PubMed ID: 29909447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human disease glycomics: technology advances enabling protein glycosylation analysis - part 1.
    Everest-Dass AV; Moh ESX; Ashwood C; Shathili AMM; Packer NH
    Expert Rev Proteomics; 2018 Feb; 15(2):165-182. PubMed ID: 29285957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent advances in mass spectrometry-based glycoproteomics.
    Frost DC; Li L
    Adv Protein Chem Struct Biol; 2014; 95():71-123. PubMed ID: 24985770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glycoproteomics: Charting new territory in mass spectrometry and glycobiology.
    Malaker SA
    J Mass Spectrom; 2024 Jun; 59(6):e5034. PubMed ID: 38726698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical glycomics for the diagnosis of congenital disorders of glycosylation.
    Abu Bakar N; Lefeber DJ; van Scherpenzeel M
    J Inherit Metab Dis; 2018 May; 41(3):499-513. PubMed ID: 29497882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of nano-LC-based glycomics towards biomarker discovery.
    Hua S; Lebrilla C; An HJ
    Bioanalysis; 2011 Nov; 3(22):2573-85. PubMed ID: 22122604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycan analysis by modern instrumental methods.
    Pabst M; Altmann F
    Proteomics; 2011 Feb; 11(4):631-43. PubMed ID: 21241022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Databases and Associated Tools for Glycomics and Glycoproteomics.
    Lisacek F; Mariethoz J; Alocci D; Rudd PM; Abrahams JL; Campbell MP; Packer NH; Ståhle J; Widmalm G; Mullen E; Adamczyk B; Rojas-Macias MA; Jin C; Karlsson NG
    Methods Mol Biol; 2017; 1503():235-264. PubMed ID: 27743371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of protein N-glycosylation in 2-DE: Erythropoietin as a study case.
    Llop E; Gallego RG; Belalcazar V; Gerwig GJ; Kamerling JP; Segura J; Pascual JA
    Proteomics; 2007 Dec; 7(23):4278-91. PubMed ID: 17973294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glycan reductive isotope labeling for quantitative glycomics.
    Xia B; Feasley CL; Sachdev GP; Smith DF; Cummings RD
    Anal Biochem; 2009 Apr; 387(2):162-70. PubMed ID: 19454239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of methods for profiling O-glycosylation: Human Proteome Organisation Human Disease Glycomics/Proteome Initiative multi-institutional study of IgA1.
    Wada Y; Dell A; Haslam SM; Tissot B; Canis K; Azadi P; Bäckström M; Costello CE; Hansson GC; Hiki Y; Ishihara M; Ito H; Kakehi K; Karlsson N; Hayes CE; Kato K; Kawasaki N; Khoo KH; Kobayashi K; Kolarich D; Kondo A; Lebrilla C; Nakano M; Narimatsu H; Novak J; Novotny MV; Ohno E; Packer NH; Palaima E; Renfrow MB; Tajiri M; Thomsson KA; Yagi H; Yu SY; Taniguchi N
    Mol Cell Proteomics; 2010 Apr; 9(4):719-27. PubMed ID: 20038609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mass spectrometry and glycomics.
    Zaia J
    OMICS; 2010 Aug; 14(4):401-18. PubMed ID: 20443730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced glycan nanoprofiling by weak anion exchange preparative chromatography, mild acid desialylation, and nanoliquid chromatography-mass spectrometry with nanofluorescence detection.
    Kalay H; Ambrosini M; Chiodo F; van Kooyk Y; García-Vallejo JJ
    Electrophoresis; 2013 Aug; 34(16):2350-6. PubMed ID: 23893432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advances in LC-MS/MS-based glycoproteomics: getting closer to system-wide site-specific mapping of the N- and O-glycoproteome.
    Thaysen-Andersen M; Packer NH
    Biochim Biophys Acta; 2014 Sep; 1844(9):1437-52. PubMed ID: 24830338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.